Conmed (CNMD) Tops Q1 EPS by 6c, Raises Guidance
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $34.67 +0.76%
EPS Growth %: -5.2%
Financial Fact:
Total operating expenses: 87.36M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: -5.2%
Financial Fact:
Total operating expenses: 87.36M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q1 EPS of $0.66, $0.06 better than the analyst estimate of $0.60. Revenue for the quarter came in at $295.5 million versus the consensus estimate of $266.67 million.
GUIDANCE:
Conmed sees FY2023 revenue of $1.21-1.25 billion, versus the consensus of $1.19 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Oracle (ORCL) Tops Q4 EPS by 16c, Offers Guidance
- Stitch Fix (SFIX) Tops Q3 EPS by 4c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
